In August, the number of investors who had short positions in Agenus Inc. saw a significant increase from the previous month (NASDAQ: AGEN). As of August 15th, there were 17,740,000 shares on loan, an increase of 7.5% compared to 16,510,000 on loan as of July 31st. Considering an average daily trading volume of 5,000,000 shares, the current short-interest ratio is 3.5 days. This number is taken into consideration. Institutional investors and hedge funds have recently modified how they hold their positions in the company in response to recent developments. Deep Track Capital LP enhanced its interests in Agenus during the first three months of 2018, bringing the total value of such assets to $34,436,000. During the second quarter, State Street Corporation achieved a 30.9% gain in the proportion of Agenus shares it owned. State Street Corporation now holds 23,243,261 shares, with a market cap of $45,092,000, following purchasing an additional 5,484,637 shares during the most recent quarter. A 77.1% increase in Renaissance Technologies LLC’s ownership holding in Agenus occurred over the first three months of 2018.
Renaissance Technologies LLC currently has 4,922,715 shares in the biotechnology company after purchasing an additional 2,143,000 shares over the preceding quarter to bring its total number to 4,922,715. As determined by the market, the current value of these shares is $12,110,000. D. E. Shaw & Co., Inc. boosted the proportion of Agenus shares it owned by 63.8% over the last three months of 2018. D. E. Shaw & Co., Inc. now owns 5,005,974 shares of the biotechnology company’s stock after purchasing an additional 1,950,325 shares in the last quarter. The store is currently valued at $16,119,000. Finally, Rafferty Asset Management LLC increased the proportion of its Agenus holdings in its portfolio by 241.7 percent during the year’s final three months. During the most recent quarter, Rafferty Asset Management LLC bought an additional 1,158,245 shares of the biotechnology company’s stock, which increased the firm’s holdings in the company’s stock. This brings the total number of shares the company has acquired to 1,637,638, bringing the total value of those shares to $5,273,000. Currently, 51.89% of the company’s shares are owned by institutional investors, such as hedge funds and other types of investment companies. NASDAQ: AGEN was first available for trading on Tuesday with an opening price of $2.66. The company’s price-to-earnings ratio is 26.60, and its beta value is 1.21. According to the stock exchange, the corporation’s market value is $753.21 million.
The current price of Agenus represents a one-year high of $6.79, while the current price of Agenus represents a one-year low of $1.25. The current price of the stock, which is trading at $2.57, is higher than its 50-day simple moving average, which is currently set at $2.32. Agenus (NASDAQ: AGEN) announced the publication of its quarterly financial results on August 9th, a Tuesday. The biotechnology company reported a quarterly profit of $0.17 per share, which was $0.06 more than analysts’ estimate of $0.23. During the year, Agenus accumulated a net margin of 3.07% and an equity return of 11.65%. The earnings per share for the current year are $0.37 less than what they were during the same quarter of the previous year compared to those statistics. Market analysts’ forecasts indicate that during the current fiscal year, Agenus will have a loss equal to-0.7 cents on each share. TheStreet downgraded their rating of Agenus from “c-” to “d” in a separate evaluation published on Friday, May 27th. This change was made in response to the overall performance of the company.
Agenus, Inc. is an immuno-oncology company in the clinical testing phase of its business. The company is responsible for conducting research and development of immuno-oncology treatments in the United States and other nations. Retrocyte Display is a platform for the expression of antibodies that may be used to locate human and humanized monoclonal antibodies. It is one of the products this company offers to its customers, in addition to display technologies.
